Oct. 31, 2016 — Westminster, Colo.—

Surefire Medical, Inc. today announced that Amy Davalle joined the company as the Vice President of Sales for North America.

“Amy is a seasoned medical device executive with more than 25 years of experience who is passionate about high growth, complex medical markets,” said James E. Chomas, CEO and President of Surefire Medical. “We are thrilled to have her lead our North American sales team and continue our efforts to partner with physicians to effectively deliver targeted therapy to cancer patients.”

Davalle has held various positions of increasing responsibility from top sales professional to leading a high performing team of more than 135 sales professionals as VP of Sales. During her time at Guidant/Boston Scientific, she was responsible for the integration strategy of Maquet Cardiovascular following the acquisition. Ms. Davalle served as regional VP of Sales at Smith and Nephew as well as the VP of Sales for the medical start-up company MedicalCue.

About Surefire Medical
Surefire Medical is inventing the future for cancer care with advanced treatment technology. We are pioneers, developing liver cancer infusion systems that overcome the limitations of traditional tools and delivery methods. Clinical discoveries combined with new, precise technology enable physicians to target tumors with superior accuracy, control and protection. Our Colorado-based team of physicians, engineers and researchers are united in a mission to progress cancer care and offer new hope to patients. Learn more: www.surefiremedical.com.


Clinical Data Shows Surefire Technology Achieved 79% Objective Response versus 37% Using a Standard Microcatheter in Treating Primary Liver Cancer. Study presented at SIR 2017 Annual Scientific Meeting.